Another report has found that FAT1 upregulation in lung cancer enhanced transforming growth factor-β and epithelial-mesenchymal transition signaling, increased CAF abundance, reduced CD8+ T cell infiltration, and was linked to low TMB 40. The gene discussed is FAT1; the disease is lung cancer.